High number of PD‐1 positive intratumoural lymphocytes predicts survival benefit of cytokine‐induced killer cells for hepatocellular carcinoma patients

BACKGROUND & AIMS: Adjuvant cytokine‐induced killer (CIK) cells treatment has shown potential in reducing the recurrence rate and prolonging the survival of patients with hepatocellular carcinoma (HCC). We aimed to identify the best predictive biomarker for adjuvant CIK cells treatment in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Boyang, Shen, Lujun, Wang, Kefeng, Jin, Jietian, Huang, Tao, Chen, Qifeng, Li, Wang, Wu, Peihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099434/
https://www.ncbi.nlm.nih.gov/pubmed/29356308
http://dx.doi.org/10.1111/liv.13697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099434/
https://www.ncbi.nlm.nih.gov/pubmed/29356308
http://dx.doi.org/10.1111/liv.13697

Ejemplares similares